Pharmacy Seal

Patrick J. Davis, Ph.D.

COLLEGE OF PHARMACY

THE UNIVERSITY OF TEXAS AT AUSTIN

 

Office of the Associate Dean for Academic Affairs ¥ PHR 5.112D ¥ Austin, Texas 78712-1074

Campus Mail Code A1900 ¥  TEL (512) 475-9751 ¥ FAX (512) 232-1893 ¥
Email:  davispj@mail.utexas.edu

 

Pharmacotherapy IIA (PHR 375E)

Spring 2009, Mondays 9-12 a.m.

Antimicrobials Module (Whole Course) – First Day Handout

 

Faculty:                           Dr. Russell Attridge, Pharm.D. (Pharmacotherapy)

                                          Dr. David Burgess, Pharm.D. (Pharmacotherapy)

                                          Dr. Patrick Davis, Ph.D.  (Med Chem), Course Coordinator

                                          Dr. Asma Lat, Pharm.D. (Pharmacotherapy)

                                          Dr. Andrea Mora, Pharm.D. (Pharmacotherapy)

                                          Dr. Dannielle O'Donnell, Pharm.D. (Pharmacy Practice)

                                          Dr. Warunee Srisupha-olarn, Pharm.D. (Pharmacotherapy)

                               

 

Course Texts:         1.   Goodman & Gilman, Pharmacol. Basis of Therapeutics, 11th Edition, 2005.

                                          [Available Online]

2.     Dipiro, Talbert, Yee, et al. Pharmacotherapy: A Pathophysiologic Approach, 7th. Edition, Appleton & Lange, 2008.

3.     Foye, Principles of Medicinal Chemistry, 5th (2003) or 6th (2007) Edition Lippincott, 2007.

                                    Note:  Exam questions may come from assigned text or web-based readings.

Web Resources:    1.   The official Blackboard® web site for this course can be accessed either through UTDirect or via http://courses.utexas.edu.  Either access point is UTEID-protected, and provides you links to the courses in which you are currently enrolled (make sure you access the correct Pharmacotherapy course since you are enrolled in three such courses).  You are strongly encouraged to visit this site for additional resources associated with this course (your grades, electronic quizzes, powerpoint presentation, previous exams, the discussion board, contacting faculty by Email, electronic versions of suggested and required readings and hyperlinks).

    The website will also be used for official, course-related announcements and for exchange class information and questions via the discussion board.  Be aware that any message posted to the discussion board are available to all enrolled students and faculty.

 

    If you encounter problems with accessing Blackboard® please contact the ITS helpdesk at: 512-475-9400 or the FAQ's at www.utexas.edu/academic/blackboard/answers


 

2.     You may also contact faculty members directly via phone or Email.

Dr. Russell Atridge (210-567-8355) rta65@mail.utexas.edu
Dr. David Burgess (210-567-8355) burgessd@uthscsa.edu
Dr. Patrick Davis (475-9751; 892-3660) davispj@mail.utexas.edu
Dr. Asma Lat (210-567-8355) asma.lat@gmail.com
Dr. Andrea Mora (210-567-8355) andrealeigh917@aol.com
Dr. Dannielle O'Donnell (512-248-8099)
odonnell@mail.utexas.edu
Dr. Warunee Srisupha-olarn (210-567-8355) srisuphaolaw@uthscsa.edu

Faculty are expected to inform students concerning their office hours (including electronic office hours, if appropriate) during their first lectures in the course.

 

3.    Taped and video-streamed recordings of lectures are intended to facilitate learning for those students who find this type of supplementation useful; they are not a substitute for attending class. Although recordings of these lectures will initially be available to you for the semester, this is for supplementation only; your instructors expect you to attend all scheduled lectures. If attendance becomes an issue, videostreaming availability may be reduced to a two-week period following the lecture.  If an individual faculty member chooses to not make his/her lectures available by videotape and/or videostreaming, it is that faculty member's responsibility to so inform you.  It is also faculty prerogative as to whether to administer announced or unannounced quizzes during lectures (be sure to bring your classroom response system (CRS) "clickers" to each and every class).  If a faculty member chooses to do so, the points for these quizzes will replace questions on their portion of the upcoming exam.

 


Viewing video-streamed recordings of lectures is primarily intended for on-campus computer facilities (e.g., LRC Library, 3.116 computer lab, or other computer facilities available on your specific campus).  However, it should be possible to view the streaming video off-campus using RoadRunner® or DSL broadband connections.  Your faculty are not in a position to troubleshoot your video-streaming problems, so please do not ask them to do so; rather, you should access the LRC website at http://www.utexas.edu/pharmacy/resources/lrc to address those problems.  Any other questions should be directed to the LRC at fudell@mail.utexas.edu.

 


 

Spring 2009, Mon 9-12, PHR 3.106

Antimicrobials Module (Whole Course) – Lecture Schedule

 

 

Lec

Faculty

Date(s)

Topic

 

 

 

 

0.5

Davis

Jan 26

I.     Introduction to the Antimicrobials Module (Road Map)

 

 

 

 

II.    General Concepts in Antimicrobial Therapy

 

1.5

Davis

Jan 26

       A. Resistance Development to Antimicrobials

1.0

Davis

Jan 26

       B. Classification of Antibiotics a/c Mode of Action

1.0

Burgess

Feb 2

       C. Review of Medical Microbiology

1.0

Burgess

Feb 2

       D. Sensitivity Testing

2.0

Burgess

Feb 2, Feb 9

       E. General Principles of Antimicrobial Therapy

 

 

 

                           Exam 1 [February 18th]

 

 

 

 

 

 

 

III.   Antimicrobial Classes & Introduction to
       Their Therapeutic Applications

 

8.0

Davis

Feb 9-Feb 23

       A. Cell Wall Synthesis Inhibitors

 

 

 

               1.   b-Lactam Antibiotics

 

 

 

                     a)  Penicillins

 

 

 

                     b)  Cephalosporins

 

 

 

                     c)   Non-Classical b -Lactams

 

 

 

               2.   Glycopeptides (vancomycin, teichoplanin)

 

 

 

               3.   Other Agents (bacitracin, cycloserine)

3.0

Burgess

Mar 2

               4.   Intro to Clinical Pharmacology of b-Lactams

 

 

 

 

                           Exam 2 [March 11th]

 

 

 

 

3.0

Davis

Mar 9

       B. Protein Synthesis Inhibitors

 

 

 

               1.   Tetracyclines

 

 

 

               2.   Aminoglycosides

 

 

 

               3.   Macrolides

 

 

 

              4.    Other Agents

 

 

Spring Break

 

3.0

Burgess

Mar 23

       C. Intro to Clinical Pharmacol of Protein Synth Inhib

1.0

Davis

Mar 30

       D. Inhibitors of Nucleic Acid Synthesis or Function

 

 

 

               1.   Rifampin/Rifabutin

 

 

 

               2.   Quinolones

1.0

Davis

Mar 30

       E. Inhibitors of Folate Synthesis (sulfonamides,                trimethoprim

F. Antimicrobials With Other Modes of Action

1.    Agents Affecting Membranes

2.    Agents Affecting Lipopolysaccharides

 

 

 

 

2.0

Burgess

Mar 30, Ap 6

       G. Intro to Clinical Pharmacology

               1.  Nucleic Acid Agents

                  2.  Folate Inhibitors

               3.  Agents with Other Mechanisms of Action

 

 

 

 

                           Exam 3 [April 15th]

 

 

 

 

1.0

Burgess

Ap 6

IV.   Intro to Pharmacodynamics of Antimicrobial Agents

 

 

 

 

V.    Therapeutic Management of Disease States

 

1.0

Burgess

Ap 6

       A. Surgical Prophylaxis

1.0

Burgess

Ap `13

       B. Endocarditis

1.0

Attridge

Ap 13

       C. Community-Acquired Pneumonia

1.0

Burgess

Ap 13

       D. Hospital-Acquired Pneumonia

1.0

Burgess

Ap 20

       E. Upper Respiratory Tract Infections

1.0

Burgess

Ap 20

       F. Urinary Tract Infections

1.0

Srisupha-olarn

Ap 20

       G. Tuberculsosis

1.0

O'Donnell

Ap 27

       H. Sexually Transmitted Diseases

1.0

Mora

Ap 27

       I.   Meningitis

1.0

Lat

Ap 27

       J.  GI & Intra-Abdominal Infections

 

 

 

                           Exam 4 [May 6th]

1.0

Burgess

May 4

       K. Skin & Soft Tissue Infections

1.0

Burgess

May 4

       L. Bone & Joint Infections

1.0

Burgess

May 4

 

       M.   Sepsis

 

42

 

 

Total Number of Lectures

 

Final Exam, which will include Topics K-M, date to be announced

 


Pharmacotherapy IIa (PHR 375E)

Course Policies

Examinations:

 

There will be four 90 minute summary examinations throughout the semester, plus a comprehensive final administered during the Final Exam. Semester exams will be given on Wednesday mornings from 8:00-9:30 am, in W.C. Hogg (1.120) according to the following schedule:

 

Exam Date & Time

Location

Coverage

Faculty

Points

Wed, Feb 18, 8AM

WCH 1.120

Sec I-II

Davis, Burgess

70

Wed, Mar 11, 8AM

WCH 1.120

Sec IIIA

Davis, Burgess

110

Wed, Ap 15, 8AM

WCH 1.120

Sec IIIB-IIIG

Davis, Burgess

100

Wed, May 6, 8AM

WCH 1.120

Sec IV-VJ

Burgess, O'Donnell, Attridge, Srisupha-olarn, Mora, Lat

110

Final Exam

May 13-19

TBA

VK-VM and
Cumulative

Burgess

All Faculty

30
160

 

Exam weighting is based upon the number of lectures applying to that exam (Total = 580 pts).  The format and emphasis for exams is entirely the prerogative of the faculty, irrespective of exam format and emphasis in previous exams.

 

It is also faculty prerogative as to whether to administer announced or unannounced quizzes during lectures (be sure to bring your classroom response system (CRS) "clickers" to each and every class).  If a faculty member chooses to do so, the points for these quizzes will replace questions on their portion of the upcoming exam.


Students must arrive on time for examinations.
  All instructions and corrections will be made at the beginning of the examination period and will not be repeated.  Semester exams will begin promptly at the designated hour and will be picked up after exactly 90 minutes. The final examination will last three hours. Students arriving after any students have completed the exam and left the room may not be allowed to sit for the exam, and may receive a score of zero for the exam.

 

No allowances will be made for an exam being missed, other than documented illness or emergency.  The student must contact the course coordinator for confirmation prior to the exam.  If permission is granted to delay the exam, it is the student responsibility to complete the College Form titled "Student Request for Alternate Exam Time" for final consideration and final approval by the Faculty member.  In this event, the nature of the make-up will be at the discretion of the course coordinator (oral, written, increased weighting on the final, etc.).  An unexcused absence from an exam may result in a grade of "zero" for that exam.

 

The grading of objective questions will be based upon the scantron sheets turned in; i.e., not on answers written on the exam papers.  After the exams have been graded and an item analysis performed (Measurement & Evaluation Center), questions may be discarded at the discretion of the Course Coordinator before arriving at final grades.

 

 

 

Return of Exams; Posting Class Scores & Keys:

 

Your summary examination and scantron copy will be returned to you within a reasonable time after taking the exam.  Following the grading of each exam, the exam key will be posted as an "Announcement" on the Blackboard® course website.  Individual student scores can be accessed using the Blackboard® "Gradebook" (only you have access to your grades), and individual grades will not be publicly posted in any manner. 

 

Post-Exam Remarks and Reconsideration Requests:

 

If there is a disagreement over the answer to a specific question, the student should present his/her exam plus a written explanation (with appropriate documentation) to the instructor within 72 hours of the listserv announcement of posting of the exam results & key as described above.  Documentation may include statements from textbooks, handouts, packets, or current scientific reprints; lecture notes are not authoritative documentation.  The explanation must be clear, rational, and concise. (This policy does not apply to addition or other grading errors).  Copy the course coordinator (Dr. Davis) on your email submissions.  Note that faculty are instructed to not respond to reconsideration requests until the deadline has passed, so do not expect an immediate response to your request (be patient).

 

Final Exam Re-Examination Policy: 

 

The re-examination policy for this course will follow the General Information Catalog (GIC) and College of Pharmacy policies for the University, which reads as follows: "Only a student who has a grade average of at least a C on all class work and lab work submitted before the final exam (in this course, >70% on each exam)  may request a temporary delay of the final course grade because he or she failed the final examination (i.e., <65%), which is the examination given during the final exam period as printed in the official examination schedule.  If the petition is denied by the instructor, the student's final course grade will remain as originally determined.  If the petition is granted by the instructor, the grade on the reexamination will be substituted for the grade on the original exam in determining the student's final course grade, provided the student earns at least a C on the reexamination.  If the grade on the reexamination is less than a C (in this course, <70%), a final course grade of F must be recorded."

 

All students who are eligible for re-examination according to the University criteria specified above will be notified by the Course Coordinator within 24 hrs of posting the final examination scores, and must reply within the specified time as to whether they will be taking the re-examination. Those students who choose to take the re-examination will be awarded a course grade of "X" until the re-examination is evaluated and the final course grade computed.

 

Module Mastery:

 

Because of the importance of each and every therapeutic module, a student doing very well on one module while failing another module (and having an overall average that would be passing) is no longer acceptable.  Students must pass each and every module with a grade of at least 70% in order to pass the course.  If a module is not passed on the summary exam(s), that portion of the comprehensive final will be scrutinized to assess whether the student has finally mastered the material.  If the student does not achieve 70% on that portion of the comprehensive final with this second attempt, a course grade of "F" will be assigned. .  If the student does demonstrate mastery, the score originally attained on the summary exam still applies (i.e., the first score earned) and will be used to calculate the final course grade. For those students who do not demonstrate module mastery on material related to the non-cumulative portion of the final exam, there will be one makup exam given over just that material.  The student must pass this second opportunity to demonstrate module mastery or a grade of F will be assigned an F in the course.  If the student does pass this second opportunity to demonstrate module mastery (by score 70% or higher), a score of 70% (a minimum passing grade) will be used in the calculating the module.   The best advice is to achieve a passing score on the module in the first place, and if not, make sure that you review your errors on the summary exam(s) with the appropriate faculty to address any deficiencies before the final.

 

In this particular course, there is one module (antibacterial chemotherapy), representing the entire course.

 

Course Grading:

 

            A =      90 - 100%

            B =      80 - 89%

            C =      70 - 79%

            D =      65 - 69%

            F =      Below 65%

 

This scale may be curved more leniently in the final analysis of grades at the discretion of the instructors.

 

Academic Integrity:

 

The "Statement on Scholastic Integrity of the College of Pharmacy" reads as follows:  "Pharmacy practitioners enjoy a special trust and authority based upon the profession's commitment to a code of ethical behavior in its management of client affairs.  The inculcation of a sense of responsible professional behavior is a critical component of professional education, and high standards of ethical conduct are expected of pharmacy students.  Students who violate University rules on scholastic dishonesty are subject to disciplinary penalties, including failure of the course involved and dismissal from the college and/or the University.  Since dishonesty harms the individual, fellow students, and the integrity of the University and the College of pharmacy, policies of scholastic dishonesty will be strictly enforced in this class".

 

Students are expected to work independently on all examinations. Any student caught cheating will be given an "zero" on the exam (minimum).  Any student suspected of dishonesty will be reported to the Dean of the College of Pharmacy and to the Dean of Students, as per University regulations.  Students are expected to have read and understood the current issue of the General Information Catalog published by the Registrar's Office for information about procedures and about what constitutes scholastic dishonesty.

 

 

Students with Disabilities:

 

The University of Texas at Austin provides upon request appropriate academic accommodations for qualified students with disabilities. All University rules concerning accommodations must be followed, including the student arranging for special accommodations prior to each examination.  In the absence of such prearrangement, the student will be assumed that the student is not requesting special accommodations for that exam, and will be expected to take the exam with the rest of the class at the regularly scheduled exam time.   For more information, contact the Office of the Dean of Students at 471-6259,  471-4641 TTY.

 

 


Return to Guide.

Last Reviewed: June 10, 2009